Our extensive range of catalogue products is suitable for Light and Electron Microscopy a well as Western blotting. In addition to our wide selection of standard products we can also custom conjugate a provided protein or oligonucloetide.

British Biocell International, part of the AIM listed 'BBI Holdings' group is recognised globally for the production of superior quality gold reagents which are used within lateral flow rapid diagnostic tests for the 'Point of Care' (POC) market.

Since the company developed a unique 'in-house' recipe for the manufacture of superior quality gold nanoparticles in 1986, the company has grown significantly and now offers a growing range of products and services to a global customer base. BBInternational's products and OEM services range from the supply of bulk gold colloid through to high volume manufacture of rapid tests.

The key to BBInternational's success is a proactive focus on rapidly changing market conditions and the ability to exploit key market opportunities.

BBInternational is now the partner of choice for many global blue chip diagnostic companies.

We welcome Shareholders and prospective Shareholders to look through the comprehensive information about British Biocell International and BBI Holdings on the following pages. However, should you have any questions or require further information; please contact us through the link below.

BBI Holdings Plc is incorporated in England and Wales (Reg no.03898291) and its operations are based mainly in the UK.